Excellims Corporation
PrivateLast Round
Debt
Apr 28, 2020
Total Funding Raised
$2.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Excellims Corporation operates in Healthcare & Life Sciences and is based in Acton, Massachusetts. Its latest recorded funding round was a Debt round in April 2020.
Excellims Corporation is a scientific instrument company that develops and manufactures high-performance ion mobility spectrometry (HPIMS) and ion mobility mass spectrometry (IMS-MS) systems for chemical detection in pharmaceutical, clinical, and security applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Pharma Supply Chain, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Excellims Corporation Comparables
Compare Excellims Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOBILion Systems | 78% | |
| 908 Devices Inc. | 77% | |
| Danaher | 74% |
For institutional investors. Book with your work email.
Excellims Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 28, 2020 | ||||
| Accelerator | May 20, 2014 | ||||
| Grant | Sep 1, 2011 | ||||
| Grant | Jun 15, 2010 | ||||
| Grant | Sep 2, 2008 | ||||
Grant | Jul 1, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Excellims Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Department of Homeland Security | Grant |
| Massachusetts Life Sciences Center | Accelerator |
| Small Business Administration | Debt |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 195% MoM, reaching 2K.
- Mar 2, 2026
Monthly visitors grew 124% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Excellims Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Excellims Corporation's valuation, stock price, and market status.
Is Excellims Corporation a public or private company?
Excellims Corporation is a private company.
What is the current stock price of Excellims Corporation?
Excellims Corporation is a private company, so its shares have no public market price. Caplight tracks Excellims Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Excellims Corporation worth (valuation)?
Valuation information for Excellims Corporation is not publicly available.
Can I buy Excellims Corporation stock?
Excellims Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Excellims Corporation's last funding round?
Excellims Corporation's most recent funding round was Debt on April 28, 2020.
Who are the main investors in Excellims Corporation?
Key investors in Excellims Corporation include Massachusetts Life Sciences Center.
Will Excellims Corporation IPO soon?
No public IPO plans have been announced for Excellims Corporation.
How can I track Excellims Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Excellims Corporation's shares on secondary markets.